The UAE's Ministry of Health and Prevention has unveiled new technology to detect counterfeit or low-quality drugs posing great health threats to the community.
The TruScan RM Analyzer is especially helpful to patients suffering from chronic diseases, heart ailment and cancer, and is part of the ministry's commitment to protect patients in need of medicine.
A statement said that the TruScan RM analyzer also enables drug inspection teams in the country to make informed and timely decisions concerning the release of all drug shipments entering the UAE.
The World Customs Organisation has placed the value of counterfeit medicines at $200 billion a year globally.
Dr Amin Hussein Al Amiri, the Ministry’s Assistant Undersecretary for Public Policy and Licensing, said the country has been fighting the spread of counterfeit medicines in the local market by implementing preventive measures, building a quality control laboratory, and conducting research on medical and other health products.
Al Amiri said ministry-employed pharmacists stationed in land, air, and seaports are presently using the TruScan RM Analyzer, which will be rolled out to all local ports.
According to Al Amiri, the device performs accurate, reliable, and rapid verification of a broad range of chemical compounds.
Significant information is stored in the device’s database to be used to identify and verify samples.
Many international organizations are currently using TruScan RM Analyzer including the US Food and Drug Administration (FDA), the Saudi Food and Drug Administration (SFDA) and the UK Medicines and Health Care Products Agency (MHRA), in addition to pharmaceutical companies Sanofi, Novartis, Merck, and Pfizer.